Showing results (61-70 of 212) with videos related to
Sort By:
Pageof 22
Helicobacter|March 4, 2026
Optimizing Benefits-Harms of H. pylori Screen-and-Treat Programs Tailored to the Regional SettingsDuco T Mülder, Yi-Chia Lee, Mario Dinis-Ribeiro, et al.The American Journal of Gastroenterology|April 20, 2004
Consumer usage patterns of nonprescription histamine2-receptor antagonistsChih-Wen Shi, Ian M Gralnek, Gareth S Dulai, et al.Helicobacter|November 10, 2018
High-risk symptoms do not predict gastric cancer precursorsBen Da, Niraj Jani, Nikhil Gupta, et al.Digestive Diseases and Sciences|June 30, 2010
Endoscopic therapy for peptic ulcer hemorrhage: practice variations in a multi-center U.S. consortiumBrintha K Enestvedt, Ian M Gralnek, Nora Mattek, et al.Gastrointestinal Endoscopy|October 26, 2010
Prokinetics in acute upper GI bleeding: a meta-analysisAlan N Barkun, Marc Bardou, Myriam Martel, et al.Journal of Clinical Gastroenterology|September 15, 2004
Racial differences in the impact of irritable bowel syndrome on health-related quality of lifeIan M Gralnek, Ron D Hays, Amy M Kilbourne, et al.Journal of Clinical Gastroenterology|February 6, 2019
An Intraprocedural Endoscopic Cleansing Device for Achieving Adequate Colon Preparation in Poorly Prepped PatientsJavier Pérez Jiménez, Lucas Diego Bermúdez, Ian M Gralnek, et al.The American Journal of Gastroenterology|August 28, 2004
Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease?Fasiha Kanwal, Ron D Hays, Amy M Kilbourne, et al.The American Journal of Medicine|May 3, 2006
Comparing rates of dyspepsia with Coxibs vs NSAID+PPI: a meta-analysisBrennan M R Spiegel, Mary Farid, Gareth S Dulai, et al.JGH Open : an Open Access Journal of Gastroenterology and Hepatology|November 29, 2018
Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn's disease activityEran Zittan, Orlaith B Kelly, Ian M Gralnek, et al.Pageof 22